Study Links Specific Brain Stimulation Frequency to Speech Speed in Parkinson's Disease
Researchers found that low-frequency deep brain stimulation in the subthalamic nucleus selectively reduces a specific frequency band (15-23 Hz) associated with slower speech in Parkinson's disease patients. The study suggests this neural activity pattern could serve as a biomarker for speech tempo modulation. This finding may help optimize deep brain stimulation treatments to improve speech problems in Parkinson's patients.
A bioRxiv preprint reports that subthalamic nucleus deep brain stimulation (STN-DBS) at low frequencies modulates narrow beta subbands in Parkinson's disease, with particular effects on the 15-23 Hz power range. The researchers observed a negative association between activity in this subband and speech tempo, and found that low-frequency stimulation improved articulatory rate in patients. The authors propose that the 15-23 Hz subband dynamics could function as a neural marker for speech-tempo-related modulation, potentially enabling more targeted therapeutic approaches. This work contributes to understanding the neural mechanisms underlying speech impairment in Parkinson's disease and the effects of deep brain stimulation on motor control.
What's missing
The study's sample size, patient demographics, statistical significance thresholds, and whether findings have been validated in independent cohorts are not specified in the provided abstract. Additionally, the mechanisms by which this specific frequency band influences speech motor control remain to be elucidated.
What different sources said
- bioRxivCenter
STN-DBS frequency-tuned beta subband dynamics are associated with speech tempo in Parkinson's disease
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.